WRAL Tech Wire

NCSU scientists to help spread new Novartis vaccine technology

NC biotech group hails formal dedication of the massive $1 billion Novartis plant in Holly Springs.

New Novartis plant.

Novartis drug plant in Wilson on FDA warning list

The U.S. Food and Drug Administration is taking Novartis CEO Joseph Jimenez to task with a warning letter that cites three of the company's manufacturing facilities for "significant violations" at the company's generics drug unit Sandoz.

Life science awards go to PPD, Novartis, Steve Burrill

Scrips, an international life science media and related services firm based in the U.K., honors PPD with two awards, Novartis with three, and names Burrill its lifetime achievement winner.

Novartis to cut 2,000 jobs, close 3 European plants

The drug giant, which operates a huge vaccine production and research facility in Holly Springs, says some jobs will be moved to the US as well as China and India.

New Novartis plant.

Novartis: 'Contagion' is fiction but threat is real

The movie "Contagion" is fiction, but ask Novartis executive Russell Thirsk and he'll tell you the threats it depicts are quite real.

Novartis fights patent rejection in Indian court

In a case that could affect India's role as drug provider to the developing world, the Supreme Court began hearing arguments Tuesday over whether the government had the right to deny a patent to Swiss drugmaker Novartis AG for its lifesaving cancer treatment Gleevec.

Novartis earnings, sales top analysts' expectations

Net income falls 6 percent but overall sales increase 16 percent from a year ago.

Novartis bids $470M for California-based cancer diagnostic firm

The Swiss drug maker, which is building a huge vaccine production plant in Holy Springs, is buying Genoptix.

Novartis to add 100 jobs, facilities at Holly Springs plant

The global life sciences firm will receive up to $3.7 million in state tax incentives for the expansion.

New Novartis plant.

Novartis ups offer by $1B, buys remaining 23% of eye care firm Alcon

Report: Novartis looking to buy as cash improves

The company is paying down debt from its Alcon purchase and looks to be debt-free in four years, the Financial Times said.

What pandemic? $260 million worth of H1N1 vaccine to go up in smoke

A whopping 40 million does of the vaccine expires – and another 30 million doses are likely to be unused, federal government says. GSK, Novartis were among the big H1N1 vaccine providers.

FDA slaps GSK, Novartis, Astellas for ad, Web claims

Letters sent to the three companies concerned claims made for cancer, pain and bladder-control drugs.

Local Tech Briefs: Cisco reports tandberg is finally a done deal; Novartis shows positive trial data for MS treatment; New chief for Novozymes' Va. unit

Viamet Pharmaceuticals signs license deal with Novartis topping $200M

Morrisville-based firm, which was co-founded by UNC-CH Chancellor Holden Thorp, will work with venture arm of Swiss drug giant in researching potential metal-based enzyme inhibitors.

Viamet